Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Apr;22(4):446-447.
doi: 10.1016/S1473-3099(22)00132-3.

Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India

Affiliations
Comment

Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India

Sasanka Chakrabarti et al. Lancet Infect Dis. 2022 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment in

Comment on

References

    1. Thiruvengadam R, Awasthi A, Medigeshi G, et al. Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses. Lancet Infect Dis. 2022 doi: 10.1016/S1473-3099(21)00680-0. published online Nov 25. - DOI - PMC - PubMed
    1. Chakrabarti SS, Kaur U, Singh A, et al. Of cross-immunity, herd immunity and country-specific plans: experiences from COVID-19 in India. Aging Dis. 2020;11:1339–1344. - PMC - PubMed
    1. Sette A, Crotty S. Pre-existing immunity to SARS-CoV-2: the knowns and unknowns. Nat Rev Immunol. 2020;20:457–458. - PMC - PubMed
    1. Chua H, Feng S, Lewnard JA, et al. The use of test-negative controls to monitor vaccine effectiveness: a systematic review of methodology. Epidemiology. 2020;31:43–64. - PMC - PubMed

Substances